BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26856600)

  • 1. Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.
    Boceta J; De la Torre A; Samper D; Farto M; Sánchez-de la Rosa R
    Clin Transl Oncol; 2016 Nov; 18(11):1088-1097. PubMed ID: 26856600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).
    Porta-Sales J; Pérez C; Escobar Y; Martínez V
    Clin Transl Oncol; 2016 Sep; 18(9):945-54. PubMed ID: 26693731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.
    Alarcón MDL; Estévez FV; Cabezón-Gutiérrez L; Padrós MC; Martín-Arroyo JMT; Rebollo MA; Jiménez-López AJ; Sanz-Yagüe A
    J Geriatr Oncol; 2019 Jul; 10(4):643-652. PubMed ID: 31036463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough cancer pain: twenty-five years of study.
    Mercadante S; Portenoy RK
    Pain; 2016 Dec; 157(12):2657-2663. PubMed ID: 27653423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough cancer pain: The importance of the right treatment at the right time.
    O'Hagan P; Mercadante S
    Eur J Pain; 2018 Aug; 22(7):1362-1374. PubMed ID: 29635732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations.
    Løhre ET; Klepstad P; Bennett MI; Brunelli C; Caraceni A; Fainsinger RL; Knudsen AK; Mercadante S; Sjøgren P; Kaasa S;
    J Pain Symptom Manage; 2016 Jun; 51(6):1013-9. PubMed ID: 26921493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.
    Davies AN; Elsner F; Filbet MJ; Porta-Sales J; Ripamonti C; Santini D; Webber K
    BMJ Support Palliat Care; 2018 Sep; 8(3):241-249. PubMed ID: 29875184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and characteristics of breakthrough cancer pain in an outpatient clinic in a Catalan teaching hospital: incorporation of the Edmonton Classification System for Cancer pain into the diagnostic algorithm.
    Canal-Sotelo J; Trujillano-Cabello J; Larkin P; Arraràs-Torrelles N; González-Rubió R; Rocaspana-Garcia M; Barallat-Gimeno E
    BMC Palliat Care; 2018 May; 17(1):81. PubMed ID: 29807537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP).
    Camps Herrero C; Reina Zoilo JJ; Monge Martín D; Caballero Martínez F; Guillem Porta V; Aranda Aguilar E; Carrato Mena A; Díaz-Rubio García E; García-Foncillas López J; Feijóo Saus M; López López R
    Clin Transl Oncol; 2019 Mar; 21(3):380-390. PubMed ID: 30094793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 13. Accuracy of a Diagnostic Algorithm to Diagnose Breakthrough Cancer Pain as Compared With Clinical Assessment.
    Webber K; Davies AN; Cowie MR
    J Pain Symptom Manage; 2015 Oct; 50(4):495-500. PubMed ID: 26025280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough cancer pain: review and calls to action to improve its management.
    Camps Herrero C; Batista N; Díaz Fernández N; Escobar Álvarez Y; Gonzalo Gómez A; Isla Casado D; Salud A; Terrasa Pons J; Guillem Porta V
    Clin Transl Oncol; 2020 Aug; 22(8):1216-1226. PubMed ID: 32002739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breakthrough Cancer Pain: Ten Commandments.
    Mercadante S; Cuomo A
    Value Health; 2016; 19(5):531-6. PubMed ID: 27565269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
    Villarroel PG; Padró JG; Marquina G; Jáñez NM; González EE; Antón A; Sánchez MB; Cáceres AR; López-López R; Cornejo RE; García PB; Fabregat RM; Fernández BC; Bermudo CL; Camps C
    Future Oncol; 2022 Nov; 18(35):3913-3927. PubMed ID: 36537885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting.
    Baek SK; Kim DY; Kang SY; Sym SJ; Kim YS; Lee JY
    Cancer Res Treat; 2016 Apr; 48(2):768-74. PubMed ID: 26511815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.
    ; Vellucci R; Fanelli G; Pannuti R; Peruselli C; Adamo S; Alongi G; Amato F; Consoletti L; Lamarca L; Liguori S; Lo Presti C; Maione A; Mameli S; Marinangeli F; Marulli S; Minotti V; Miotti D; Montanari L; Moruzzi G; Palermo S; Parolini M; Poli P; Tirelli W; Valle A; Romualdi P
    Drugs; 2016 Mar; 76(3):315-30. PubMed ID: 26755179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and practice of the management of breakthrough cancer pain among general practitioners providing palliative care in Shanghai, China: a cross-sectional survey.
    Yu Y; Zhang P; Chen D; Jiang SF
    BMJ Open; 2023 Sep; 13(9):e073670. PubMed ID: 37770268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non pharmacological interventions and non-fentanyl pharmacological treatments for breakthrough cancer pain: A systematic and critical review.
    Mercadante S
    Crit Rev Oncol Hematol; 2018 Feb; 122():60-63. PubMed ID: 29458790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.